Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction.
about
Influence of diabetes mellitus on heart failure risk and outcomeA comparative study of discriminating human heart failure etiology using gene expression profilesDiabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survivalCarbonic anhydrase activation is associated with worsened pathological remodeling in human ischemic diabetic cardiomyopathyInsulin Signaling and Heart Failure.Non-cardiovascular comorbidity, severity and prognosis in non-selected heart failure populations: A systematic review and meta-analysis.Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).Managing the post-myocardial infarction patient with asymptomatic left ventricular dysfunction.Neurohormonal profile of patients with heart failure and diabetesAssessment of cost and health resource utilization for elderly patients with heart failure and diabetes mellitusEarly diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides.The effect of glycaemic control and glycaemic variability on mortality in patients hospitalized with congestive heart failure.Association of antidiabetic medications targeting the glucagon-like peptide 1 pathway and heart failure events in patients with diabetes.Possible heart failure exacerbation associated with rosiglitazone: case report and literature review.The association of comorbid diabetes mellitus and symptoms of depression with all-cause mortality and cardiac rehospitalization in patients with heart failureDownregulation in GATA4 and Downstream Structural and Contractile Genes in the db/db Mouse HeartAssociation between Retinal Arteriolar and Venule Calibre with Prevalent Heart Failure: A Cross-Sectional Study.An economic evaluation of a self-care intervention in persons with heart failure and diabetesFrequent non-cardiac comorbidities in patients with chronic heart failure.Flow-Mediated Vasodilatation and Intima-Media Thickness in Patients with Coexisting Heart Failure and Diabetes Receiving Medical Therapy.Does tight glucose control prevent myocardial injury and inflammation?Animal models of insulin resistance and heart failure.Factors of cardiovascular risk in patients with type 2 diabetes and incipient nephropathyA critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus.Effects of MEK5/ERK5 association on small ubiquitin-related modification of ERK5: implications for diabetic ventricular dysfunction after myocardial infarction.Diabetes, left ventricular systolic dysfunction, and chronic heart failure.Thiazolidinediones in type 2 diabetes: a cardiology perspective.A pilot test of an integrated self-care intervention for persons with heart failure and concomitant diabetes.Glucose and insulin abnormalities in patients with heart failure.Thiazolidinedione use in elderly patients with type 2 diabetes: with and without heart failure.Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.Co-morbidities in heart failure.Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressure.Recent advances in metabolic imaging.Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.Diabetic cardiomyopathy: role of the E3 ubiquitin ligase.Type 2 Diabetes and Heart Failure: Challenges and Solutions.Coronary artery disease prevalence and outcome in patients hospitalized with acute heart failure: an observational report from seven Middle Eastern countries.Cardiac magnetic resonance imaging in heart failure: where the alphabet begins!Predictors of mortality and morbidity in patients with chronic heart failure.
P2860
Q24800363-D271969A-9AF1-4FD5-A90C-AEF29D8F45F1Q24815374-2F4A2572-8C1E-4672-9CF6-860C0A9620A8Q26827620-03514735-7A06-4240-BE84-A7B7FF685D38Q28236866-83013482-F841-44A3-99BD-67C793B9FC55Q30377910-20EF3E45-05AF-42CD-A795-CA078428BA8DQ30659393-7AE7FDBA-D9A7-4D1F-B90B-8C46F8726AEFQ31094492-4BAB5FEB-3313-4626-8D05-D7F02EA84F8CQ33229039-51A4B184-5EDE-4C8A-99BE-F00E95FA96FBQ33799053-E744E7BE-F247-46BC-9159-E614D596EA2BQ34024171-1E31D0EB-1AD6-4D3B-A9F6-6B7895595316Q34481884-CCBB5840-9362-4721-AE9B-959ACE4B4E3EQ34680795-F84E1514-E675-4047-8735-F7028EA3F320Q34771795-8B5EBDEF-50CF-4D01-847D-10B24AEF829FQ35186548-7D8FE299-C6F1-470D-B91B-D1150F91E433Q35675582-47450E2A-1030-4FBD-B84F-C1D4F02D54F3Q35855603-BAC659B5-C3B1-4767-937E-78D4B19A127CQ35867175-CDA67FC3-565B-44E7-8D5A-AF66E8CB9688Q36011926-CAD5BC7A-F69E-4998-A999-9EF98A77B512Q36046585-257BC48D-84A7-485F-8C26-1E48FEDCD740Q36334981-C1F67A46-52B0-4148-806D-3EA2BB4E1A38Q36374280-B312FA43-8228-43FE-A83E-A97750A9B800Q36944915-863750B0-F513-4F1F-9252-B02D0BD606D1Q36966203-E9D6C948-C73A-41B9-A7AE-0445BAA936C1Q37031357-12B49082-A472-45CC-9FA0-80F2994FE71CQ37038236-C7595269-F456-4375-86DC-5900C02423E0Q37143034-E378B7FD-A20C-4FA7-A3E9-311D39BF0D36Q37242253-565BB8D2-07A1-4966-913F-51196DF26132Q37647006-4ACAE59F-CA3F-45A7-B70F-EB1B2110075DQ37801130-B2E09709-8B4F-492A-B7F8-423605838A0DQ37844021-40E355F6-BA56-4F3D-9DCB-1B8FE5076B96Q37882500-6F711A6A-8DAE-4C17-9281-4EE31353A40DQ38069787-3BB1B0E2-8B05-4B0A-ADAD-E83772712C4DQ38113247-1DF8C65C-CBCD-49A9-AC4A-52A580B00C66Q38156683-DCB93FE3-38A0-41AB-AAAD-0D5B6067E181Q38374511-2C457841-A57F-4EAB-875B-B46228BD5EFEQ38687425-F036E368-15EE-4FBF-9AEC-56095EB4BFE5Q38859858-C46E9754-5827-4C8A-91BC-497C881487A9Q39200756-19FCF96A-4394-49A3-9653-4E0DBB785460Q39255836-3ECCFF3C-2245-4EB9-8CCF-2E865687AB5DQ39361079-21969336-42F9-46EB-89FF-3A1E2D564B40
P2860
Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Prognostic impact of diabetes ...... tricular systolic dysfunction.
@ast
Prognostic impact of diabetes ...... tricular systolic dysfunction.
@en
type
label
Prognostic impact of diabetes ...... tricular systolic dysfunction.
@ast
Prognostic impact of diabetes ...... tricular systolic dysfunction.
@en
prefLabel
Prognostic impact of diabetes ...... tricular systolic dysfunction.
@ast
Prognostic impact of diabetes ...... tricular systolic dysfunction.
@en
P2093
P921
P1476
Prognostic impact of diabetes ...... tricular systolic dysfunction.
@en
P2093
Drazner MH
Stevenson LW
Sweitzer NK
P304
P356
10.1016/S0735-1097(01)01408-5
P407
P577
2001-08-01T00:00:00Z